HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

15-Epi-lipoxin A(4) inhibits the progression of endometriosis in a murine model.

AbstractOBJECTIVE:
To examine the pro-resolution actions of 15-epi-lipoxin A(4) (LXA(4)) on endometriotic lesions, on the concentrations and activities of matrix metalloproteinases (MMP-2 and MMP-9) in murine endometriosis.
DESIGN:
Prospective, vehicle-controlled experimental study.
SETTING:
Animal research facility.
ANIMAL(S):
BALB/c mice.
INTERVENTION(S):
Endometriosis (EM) was induced in 30 mice. Fifteen of them were administered LXA(4) for 24 days (LXA(4) group), whereas the other 15 served as a control group (EM group). Another 15 sham-operated mice (sham-operated group) were treated with vehicles.
MAIN OUTCOME MEASURE(S):
The weight of the endometriotic lesions was measured. The concentrations, mRNA, and activities of MMP-2 and MMP-9 were determined by enzyme-linked immunosorbent assay, quantitative real-time polymerase chain reaction, and gelatin zymography, respectively.
RESULT(S):
Compared with EM group, the weight of the endometriotic lesions was decreased, the concentrations of MMP-2 and MMP-9 dropped, the mRNA levels of MMP-2 and MMP-9 in the peritoneal fluid cells and the endometriotic lesions were reduced, and the activities of MMP-2 and MMP-9 were inhibited in the LXA(4) group.
CONCLUSION(S):
LXA(4) may inhibit the progression of endometriosis possibly by lowering the concentrations and the activities of MMP-2 and MMP-9.
AuthorsQiong-Hua Chen, Wei-Dong Zhou, De-Min Pu, Qian-Sheng Huang, Tian Li, Qing-Xi Chen
JournalFertility and sterility (Fertil Steril) Vol. 93 Issue 5 Pg. 1440-7 (Mar 15 2010) ISSN: 1556-5653 [Electronic] United States
PMID19268934 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Lipoxins
  • RNA, Messenger
  • lipoxin A4
  • Matrix Metalloproteinase 2
  • Mmp2 protein, mouse
  • Matrix Metalloproteinase 9
  • Mmp9 protein, mouse
Topics
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (administration & dosage, pharmacology)
  • Ascitic Fluid (cytology, enzymology)
  • Disease Models, Animal
  • Disease Progression
  • Down-Regulation
  • Endometriosis (drug therapy, enzymology, pathology)
  • Endometrium (drug effects, enzymology, pathology, transplantation)
  • Enzyme-Linked Immunosorbent Assay
  • Estrus
  • Female
  • Gene Expression Regulation, Enzymologic (drug effects)
  • Injections, Intraperitoneal
  • Lipoxins (administration & dosage, pharmacology)
  • Matrix Metalloproteinase 2 (genetics, metabolism)
  • Matrix Metalloproteinase 9 (genetics, metabolism)
  • Mice
  • Mice, Inbred BALB C
  • RNA, Messenger (metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: